NCT06097091

Brief Summary

This randomized controlled trials study aims, first, to determine the effectiveness of a nurse-led PNE program designed by a multidisciplinary team, compared with an active control group on pain intensity, fibromyalgia (FM) severity, pain catastrophizing, and cognitive performance in patients with FM. Second, to determine the mediator role of pain catastrophizing in the effects of PNE on outcomes of interest. Third, to explore PNE-induced changes to the brain circuitry using QEEG in patients with FM.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
98

participants targeted

Target at P50-P75 for not_applicable

Timeline
3mo left

Started Sep 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress92%
Sep 2023Jul 2026

Study Start

First participant enrolled

September 6, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 18, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 24, 2023

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2026

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Expected
Last Updated

November 20, 2024

Status Verified

November 1, 2024

Enrollment Period

2.5 years

First QC Date

October 18, 2023

Last Update Submit

November 19, 2024

Conditions

Keywords

fibromyalgiacognitive functiondisease severitypain catastrophizingpain neuroscience educationpain severityquantitative electroencephalography

Outcome Measures

Primary Outcomes (2)

  • the Brief Pain Inventory-Short Form (BPI-SF)

    The BPI-SF evaluates pain in different contexts: worst pain, least pain, average pain, and current pain, rated on a 0-10 scale.

    baseline; T1 = immediately after PNE; T2 = 3th month after intervention.

  • the Fibromyalgia Impact Questionnaire Revised (FIQR)

    The FIQR includes 21 questions involving 3 domains: physical function, overall effect of fibromyalgia, and fibromyalgia symptoms (pain, fatigue, unrefreshing sleep, stiffness, anxiety, depression, tenderness to touch, memory, balance, and environmental sensitivity).

    baseline; T1 = immediately after PNE; T2 = 3th month after intervention.

Secondary Outcomes (2)

  • Pain Catastrophizing Scale(PCS)

    baseline; T1 = immediately after PNE; T2 = 3th month after intervention.

  • Psychomotor Vigilance Test (PVT)

    baseline; T1 = immediately after PNE; T2 = 3th month after intervention.

Other Outcomes (1)

  • Quantitative electroencephalography

    baseline; T1 = immediately after PNE; T2 = 3th month after intervention.

Study Arms (2)

Self-Management Education

ACTIVE COMPARATOR

Participants in the control group will receive an SME via weekly video calls over 6 weeks.

Other: Self-management education

Pain Neuroscience Education

EXPERIMENTAL

Participants in the experimental group will receive a 6-week PNE program.

Behavioral: pain neuroscience education

Interventions

A self-management of the FM handbook will be provided. SME will be delivered via weekly video calls over a 6-week period. The video call lasting for 15 minutes, will consist of reviewing the weekly self-management content (5 min), questioning and answering related to the content of the self-management handbook (5 min), and a debriefing session (5 min).

Self-Management Education

Participants in the experimental group will receive a 6-week PNE program. The PNE program that is designed to explain pain to the participants will be implemented via 6 individual face-to-face sessions, each lasting for 45 minutes over a 6-week period. Printed take-home materials will be provided to the participants to enhance learning. The goal of PNE is to increase participants' knowledge about pain to help them reconceptualize their beliefs about pain and decrease perceived threats of pain. The content will be composed according to the second edition of the book, "Explain Pain" by Butler and Mosley (2013) as well as etiologies of fibromyalgia. Accordingly, the PI has developed the preliminary PNE content.

Pain Neuroscience Education

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Participants must read and understand Chinese language.
  • According to the 2016 ACR diagnostic criteria, participants' PDS scores more than or equal to 13 points

You may not qualify if:

  • Subjects who have medical history of traumatic brain injury or neurological disorder.
  • Subjects who have present psychopathologic disorder.
  • Subjects who are cancer.
  • Subjects who are pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bio-Behavior Research Laboratory

Taipei, Taiwan

RECRUITING

MeSH Terms

Conditions

FibromyalgiaPain

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Pei-Shan Tsai, PhD

    Taipei Medical University, Taiwan

    STUDY CHAIR

Central Study Contacts

Pei-Shan Tsai, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
We will employ a triple masking protocol in which the PNE educator, participants, and data collectors will all be blinded to group assignments. In addition, we will mask the group assignment to the data analyzer.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 18, 2023

First Posted

October 24, 2023

Study Start

September 6, 2023

Primary Completion

February 28, 2026

Study Completion (Estimated)

July 31, 2026

Last Updated

November 20, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations